Publication | Closed Access

Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation

Tumor ImmunologyTumor-directed T CellsCancer ImmunosurveillanceImmunologyTherapeutic EfficacyAntigen ProcessingAutoimmunityImmunotherapyMedicineRadiation OncologyTumor Microenvironment